The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)

ConditionsHivSyphilisHBV
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorInstitut de Recherche pour le Developpement

About this trial

The TRI-MOM program aims to implement and evaluate a simplified (based on inexpensive rapid diagnostic tests), integrated (in governmental health facilities) and coordinated (between health care workers) strategy for the triple elimination of HIV, syphilis and HBV mother-to-child transmission (MTCT) in nine maternal and child health services, 5 in Burkina Faso and 5 in The Gambia.

The TRI-MOM program has two components:

1. an "intervention" component consisting of a pilot study to reinforce the antenatal screening and prevention of MTCT (PMTCT) capacities for the 3 targeted infections through the implementation of a simplified, integrated and coordinated strategy of triple elimination of MTCT. 2. an "evaluation" component which will assess the impact of the TRI-MOM strategy on PMTCT services, reduction of HBV MTCT and women empowerment.

Eligibility criteria

Qualifiers

Women attending a postnatal visit in one of the selected maternities (no maternal age limit)

Disqualifiers

Refusal to participate in the study

Unable to provide consent

Trial design

Treatments tested in this trial

  • TRI-MOM intervention

Treatment groups

2,800 Participants
are divided into 1 treatment group

Sponsors and collaborators

Institut de Recherche pour le Developpement

Lead sponsor

Centre Muraz

Collaborator

Medical Research Council

Collaborator

Institut Pasteur

Collaborator

REVS PLUS Burkina Faso

Collaborator

Young Gambian Mums Fund

Collaborator

National AIDS Control Program Gambia

Collaborator